Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

100 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Hybrid closed-loop insulin therapy and risk of severe hypoglycaemia and diabetic ketoacidosis in young people (aged 2-20 years) with type 1 diabetes: a population-based study.
Karges B, Rosenbauer J, Stahl-Pehe A, Flury M, Biester T, Tauschmann M, Lilienthal E, Hamann J, Galler A, Holl RW. Karges B, et al. Among authors: biester t. Lancet Diabetes Endocrinol. 2024 Dec 16:S2213-8587(24)00284-5. doi: 10.1016/S2213-8587(24)00284-5. Online ahead of print. Lancet Diabetes Endocrinol. 2024. PMID: 39701114 Free article.
Clinical characteristics, treatment, and treatment switch after molecular-genetic classification in individuals with maturity-onset diabetes of the young: Insights from the multicenter real-world DPV registry.
Lanzinger S, Laubner K, Warncke K, Mader JK, Kummer S, Boettcher C, Biester T, Galler A, Klose D, Holl RW. Lanzinger S, et al. Among authors: biester t. J Diabetes. 2024 Nov;16(11):e70028. doi: 10.1111/1753-0407.70028. J Diabetes. 2024. PMID: 39511990 Free PMC article.
Expected Basal Insulin Requirement During Continuous Subcutaneous Insulin Infusion Therapy by Age Group, Sex, and Body Mass Index, Based on 25,718 Young People with Type 1 Diabetes in the DPV Registry.
Biester T, Eckert A, Becker M, Boettcher C, Golembowski S, Heidtmann B, Klinkert C, Müther S, Rami-Merhar B, Holl RW. Biester T, et al. Diabetes Technol Ther. 2023 Nov;25(11):774-781. doi: 10.1089/dia.2023.0283. Epub 2023 Sep 20. Diabetes Technol Ther. 2023. PMID: 37668604 Free article.
New therapies towards a better glycemic control in youths with type 1 diabetes.
Cardona-Hernandez R, Dôvc K, Biester T, Ekhlaspour L, Macedoni M, Tauschmann M, Mameli C. Cardona-Hernandez R, et al. Among authors: biester t. Pharmacol Res. 2023 Sep;195:106882. doi: 10.1016/j.phrs.2023.106882. Epub 2023 Aug 3. Pharmacol Res. 2023. PMID: 37543096 Free PMC article. Review.
100 results